TB bacteria block key Th17 immune response

Tuberculosis remains a major global health challenge because the bacterium that causes it, Mycobacterium tuberculosis (Mtb), has evolved ways to blunt the immune system. In research led by Sarah A. Stanley, scientists investigated how the immune response to Mtb is shaped during infection. The team explored the balance between two types of T cell responses: Th1, which has long been associated with controlling Mtb, and Th17, which produces IL-17A and can help protect the lungs. Using deficient mice, the researchers showed that Mtb drives a strong Th1 response that is only partially protective, and at the same time limits production of Th17 cells. Importantly, this limitation of Th17 cells occurs in an IFN-γ independent manner, meaning it is not driven by the classic IFN-γ pathway associated with Th1 activity. These observations prompted a closer look at bacterial factors that might be actively suppressing Th17 responses during infection and how that suppression contributes to the bacterium’s ability to cause disease.

To pinpoint bacterial components that influence the immune balance, the study examined the roles of the ESX-1 type VII alternative secretion system and a bacterial lipid called PDIM. The authors report that both ESX-1 and PDIM suppress Th17 responses during infection. Infection with ESX-1 or PDIM mutants results in significantly increased Th17 T cells and elevated IL-17A cytokine levels in the lungs. Conversely, when animals lacking IL-17A were infected, the virulence of the ESX-1 and PDIM mutants was partially restored, indicating that the increased IL-17A contributed to protection. The researchers also found that although ESX-1 and PDIM elicit type I IFN, the suppression of Th17 differentiation is independent of type I IFN. Instead, ESX-1 and PDIM act to suppress production of IL-23, a cytokine that promotes Th17 differentiation, in dendritic cells located in mediastinal lymph nodes during Mtb infection.

These findings identify a previously unappreciated mechanism by which Mtb undermines a protective arm of the immune system. By showing that the ESX-1 secretion system and the PDIM lipid directly limit IL-23 production in dendritic cells and thereby reduce Th17 and IL-17A responses in the lung, the work defines a new function for two well-known Mtb virulence factors. That resolves a long-standing question in tuberculosis research about how these bacterial components contribute to disease. Understanding this immune evasion strategy helps explain why a dominant Th1 response may be insufficient for protection and points to the importance of Th17-promoting signals in controlling infection. The study suggests that reversing this suppression—by restoring IL-23 or Th17 activity—could be a strategy worth exploring in future vaccine or therapeutic research aimed at improving protection against tuberculosis.